Year-end Sale % OFF 
Abstract
Penicillin is considered to be the drug of choice in anaerobic pulmonary infections. The patient presented here illustrates some of the reasons for the failure of penicillin therapy in an anaerobic necrotizing pneumonia. Experimental and clinical evidence to date suggests a need for reappraisal of penicillin therapy in such infections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
